Volume 27, Number 1—January 2021
Research
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
Table 2
Humoral and cellular immune response to SARS-CoV-2 of COVID-19 patients and their contacts 44–102 days after symptom onset, Strasbourg, France, 2020*
ID† |
Lymphocyte count, × 109/L |
Days from symptom onset to sample collection |
SARS-CoV-2 serologic test result |
Assay results |
SARS-CoV-2–specific T-cell response (no. antigens) |
|||||
---|---|---|---|---|---|---|---|---|---|---|
Biosynex Antigen: RBD of protein S |
Abbott Architect Antigen: protein N (index value) | Euroimmun Antigen: protein S (index value) | ||||||||
IgM |
IgG |
IgG |
IgG/IgA |
|||||||
Couples with symptomatic contacts |
||||||||||
P1 | 1.3 | 58 | Pos | Neg | Pos | Pos (3.36) | Pos (2.28)/neg | Pos (5)† | ||
C1 |
1.8 |
53 |
Neg |
Neg |
Neg |
Neg |
Neg/neg |
Pos (4)† |
||
P2 | 2.0 | 51 | Pos | Neg | Pos | Pos (4.3) | Pos (2.3)/neg | Pos (7)† | ||
C2 |
1.5 |
44 |
Neg |
Neg |
Neg |
Neg |
Neg/neg |
Neg (1) |
||
P4 | 1.6 | 57 | Pos | Pos | Pos | Pos (6.48) | Pos (4.24)/pos (4.16) | Pos (4)† | ||
C4 |
1.7 |
51 |
Neg |
Neg |
Neg |
Neg |
Neg/neg |
Pos (3)† |
||
P5 | 1.6 | 68 | Pos | Pos | Pos | Pos (3.97) | Pos (4.86)/pos (2.38) | Pos (7)† | ||
C5 |
2.0 |
80 |
Neg |
Neg |
Neg |
Neg |
Neg/neg |
Pos (3)† |
||
P7 | 1.3 | 64 | Pos | Pos | Neg | Pos (4.18) | Pos (3.43)/doubtful (0.94) | Pos (4)† | ||
C7 |
2.2 |
64 |
Neg |
Neg |
Neg |
Neg |
Neg/neg |
Neg (1) |
||
P8 | 1.9 | 102 | Pos | Pos | Pos | Pos (7.55) | Pos (5.39)/pos (9.23) | Pos (5)† | ||
C8 |
1.9 |
93 |
Neg |
Neg |
Neg |
Neg |
Neg/neg |
Pos (4)† |
||
Couples with asymptomatic contacts |
||||||||||
P3 | 1.7 | 49 | Pos | Pos | Pos | Pos (8.4) | Pos (7.23)/pos (3.83) | Pos (8)† | ||
C3 |
1.5 |
NA |
Neg |
Neg |
Neg |
Neg |
Neg/Neg |
Neg (0) |
||
P6 | 2.1 | 69 | Pos | Pos | Pos | Pos (6.37) | Pos (5.73)/pos (2.49) | Pos (6)† | ||
C6 |
2.2 |
NA |
Neg |
Neg |
Neg |
Neg |
Neg/doubtful (0.85) |
Neg (1) |
||
P9 | 2.4 | 88 | Pos | Pos | Pos | Pos (7.48) | Pos (7.02)/pos (5.98) | Pos (6)† | ||
C9 |
3.0 |
NA |
Neg |
Neg |
Neg |
Neg |
Neg/neg |
Neg (1) |
||
P10 | 1.9 | 99 | Pos | Pos | Neg | Pos (2.46) | Pos (1.75)/doubtful (0.95) | Pos (5)† | ||
C10 |
1.1 |
NA |
Neg |
Neg |
Neg |
Neg |
Neg/neg |
Neg (1) |
||
P11 | 1.7 | 100 | Pos | Neg | Pos | Neg | Pos (4.01)/pos (1.72) | Pos (6)† | ||
C11 | 1.9 | NA | Neg | Neg | Neg | Neg | Neg/neg | Neg (0) |
*In ID column, same number indicates P and C are partners in 1 couple. C, contact; ID, identification; neg, negative; P, index patient; pos, positive; PBMC, peripheral blood mononuclear cells; NA, not applicable; RBD, receptor-binding domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.